ArticleScientific reports2025
Application of machine learning-based exosome-related gene profiles in precision diagnosis and treatment of osteoarthritis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Small extracellular vesicles in osteoarthritis: A double‑edged sword regulating inflammation and cartilage homeostasis (Review).International journal of molecular medicine · 2026Review
- Machine-Learning Prediction of Extracellular Vesicle Protein Sorting Expands the Characterization of Secretory Functions inJournal of fungi (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoarthritis (OA) involves a complex pathogenesis encompassing inflammation, metabolic dysregulation, and aberrant intercellular communication. Despite their crucial role as mediators of intercellular signaling, exosomes remain largely underexplored in OA. This study aims to investigate exosome-related genes (ERGs) and their roles in OA pathogenesis. Four OA-related gene expression datasets retrieved from GEO were harmonized using the ComBat algorithm to mitigate batch effects. Differentially expressed genes (DEGs) were identified through differential expression analysis and weighted gene co-expression network analysis (WGCNA). ERGs were screened utilizing the ExoCarta and Vesiclepedia databases. Core ERGs were prioritized using LASSO, random forest, and XGBoost algorithms. Predictive models were constructed and subsequently evaluated using SHAP analysis to ascertain feature importance. Additionally, pathway enrichment, immune infiltration, and molecular subtype identification were performed, followed by validation of core ERG expression via RT-qPCR in clinical samples. Integration of the four GEO datasets yielded 231 DEGs significantly enriched within OA-associated pathways (e.g., inflammation, immune cell migration, extracellular matrix remodeling). From a pool of 79 candidate ERGs, 10 core ERGs (EPB41L2, ISLR, HLA-DRB1, HLA-DRA, PGLYRP1, PTEN, TKT, CTNNB1, THSD4, ATP9A) were identified. Random forest models achieved impressive AUCs of 0.991, 1.0, and 0.935 in the training, validation, and external validation sets, respectively, demonstrating substantial clinical net benefit. SHAP analysis underscored CTNNB1 and PGLYRP1 as pivotal predictors. Core ERGs were intricately linked to immune regulation (e.g., M1 macrophage infiltration) and metabolic perturbations (e.g., fatty acid metabolism). Distinct molecular subtypes of OA were delineated based on ERG profiles, thereby revealing the inherent disease heterogeneity. RT-qPCR further corroborated the differential expression of core ERGs in clinical samples. This study comprehensively integrates exosome-related genomic data with advanced machine learning techniques to identify and validate 10 core ERGs associated with OA, thereby elucidating their pivotal roles in immunometabolic regulation. These seminal findings illuminate the intricate molecular heterogeneity of OA, concurrently offering promising novel biomarkers and therapeutic targets for early diagnosis and precision treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.